{"id":1283,"date":"2021-11-05T09:16:14","date_gmt":"2021-11-05T07:16:28","guid":{"rendered":"https:\/\/demo6.dev2.uoi.gr\/iatrikes-ypiresies\/kliniki-2\/"},"modified":"2026-02-21T23:15:32","modified_gmt":"2026-02-21T21:15:32","slug":"energeis-klinikes-dokimes","status":"publish","type":"page","link":"https:\/\/haematology.med.uoi.gr\/en\/iatrikes-ypiresies\/energeis-klinikes-dokimes\/","title":{"rendered":"\u0395\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u039c\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1283\" class=\"elementor elementor-1283\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4a48 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4a48\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;3fa6fd7&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ceb\" data-id=\"ceb\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5365 elementor-widget elementor-widget-heading\" data-id=\"5365\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0395\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u039c\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1b13280 elementor-widget elementor-widget-heading\" data-id=\"1b13280\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf\n<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-c194b03 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"c194b03\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;8a82973&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-0e46848\" data-id=\"0e46848\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5f41199 elementor-widget__width-initial elementor-widget elementor-widget-counter\" data-id=\"5f41199\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"counter.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-counter\">\n\t\t\t<div class=\"elementor-counter-title\">\u03b5\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2<\/div>\t\t\t<div class=\"elementor-counter-number-wrapper\">\n\t\t\t\t<span class=\"elementor-counter-number-prefix\"><\/span>\n\t\t\t\t<span class=\"elementor-counter-number\" data-duration=\"2000\" data-to-value=\"24\" data-from-value=\"0\" data-delimiter=\",\">0<\/span>\n\t\t\t\t<span class=\"elementor-counter-number-suffix\"><\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-98e1f13\" data-id=\"98e1f13\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-daf1f3c elementor-widget elementor-widget-counter\" data-id=\"daf1f3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"counter.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-counter\">\n\t\t\t<div class=\"elementor-counter-title\">\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ad\u03c2 \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/div>\t\t\t<div class=\"elementor-counter-number-wrapper\">\n\t\t\t\t<span class=\"elementor-counter-number-prefix\"><\/span>\n\t\t\t\t<span class=\"elementor-counter-number\" data-duration=\"2000\" data-to-value=\"9\" data-from-value=\"0\" data-delimiter=\",\">0<\/span>\n\t\t\t\t<span class=\"elementor-counter-number-suffix\"><\/span>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-59ce52e\" data-id=\"59ce52e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ce385c5 elementor-widget elementor-widget-image\" data-id=\"ce385c5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"300\" height=\"193\" src=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-300x193.jpeg\" class=\"attachment-medium size-medium wp-image-1838\" alt=\"\" srcset=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-300x193.jpeg 300w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-1024x659.jpeg 1024w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-768x494.jpeg 768w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-1536x988.jpeg 1536w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-2048x1318.jpeg 2048w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-600x386.jpeg 600w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-77963243-scaled.jpeg 1440w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-24af elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"24af\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-448e\" data-id=\"448e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2a0e9d3 elementor-widget elementor-widget-text-editor\" data-id=\"2a0e9d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u0397 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03ad\u03c7\u03b5\u03b9 \u03c0\u03c1\u03bf\u03c3\u03b5\u03bb\u03ba\u03cd\u03c3\u03b5\u03b9 <strong>\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03c6\u03ac\u03c3\u03b7\u03c2 I\u0399-IV<\/strong> \u03b5\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c0\u03c1\u03cc\u03c3\u03b2\u03b1\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03c3\u03b5 \u03ba\u03b1\u03b9\u03bd\u03bf\u03c4\u03cc\u03bc\u03b5\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03b1\u03c1\u03ad\u03c7\u03bf\u03bd\u03c4\u03b1\u03c2 \u03b1\u03be\u03b9\u03cc\u03c0\u03b9\u03c3\u03c4\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1. \u03a0\u03b1\u03c1\u03b1\u03ba\u03ac\u03c4\u03c9 \u03bc\u03c0\u03bf\u03c1\u03b5\u03af\u03c4\u03b5 \u03bd\u03b1 \u03b4\u03b5\u03af\u03c4\u03b5 \u03c0\u03bf\u03b9\u03b5\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 <strong><span style=\"color: #33cccc;\">\u03b5\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2<\/span><\/strong> \u03ba\u03b1\u03b9 \u03c0\u03bf\u03b9\u03ad\u03c2 <strong><span style=\"color: #33cccc;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ad\u03c2<\/span><\/strong> \u03c0\u03c1\u03bf\u03c2 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-642 elementor-widget elementor-widget-heading\" data-id=\"642\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u039c\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5aa4075 elementor-widget elementor-widget-heading\" data-id=\"5aa4075\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<br><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-b04c0b6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b04c0b6\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;0819c5a&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-af330e2\" data-id=\"af330e2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7d6ade8 elementor-widget elementor-widget-text-editor\" data-id=\"7d6ade8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\">TRIlogy-5 &#8211; \u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03ba\u03ad\u03bd\u03c4\u03c1\u03bf\u03c5- <span style=\"color: #993366;\">\u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03ba\u03ad\u03bd\u03c4\u03c1\u03bf\u03c5<\/span>\u00a0<\/span><\/strong><\/li><\/ul><p>A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma after 1-3 prior lines of therapy, PI E. Hatzimichael<\/p><ul><li><strong><span style=\"color: #33cccc;\">DREAMM-15 &#8211; <span style=\"color: #993366;\">\u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03ba\u03ad\u03bd\u03c4\u03c1\u03bf\u03c5<\/span>\u00a0<\/span><\/strong><\/li><\/ul><p>A Phase 2, multicenter, open label, non-randomized study to evaluate the safety and efficacy of extended dosing of belantamab\u00a0mafodotin in different combinations with standard of care regimens in participants with\u00a0relapsed-refractory multiple myeloma &#8211; PI. E. Hatzimichael<\/p><ul><li><strong><span style=\"color: #33cccc;\">TAK-339-3001 study-\u00a0<\/span><\/strong><strong><span style=\"caret-color: #993366; color: #0000ff;\"><span style=\"color: #993366;\">\u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03ba\u03ad\u03bd\u03c4\u03c1\u03bf\u03c5<\/span><\/span><\/strong><\/li><\/ul><p>Phase III Study in R\/R Multiple Myeloma Patients Receiving BCMA Therapy, PI E. Hatzimichael<\/p><ul><li><strong><span style=\"color: #33cccc;\">R5458-ONC-2246 RABCD-TA\/IND-138791 &#8211; <\/span><span style=\"caret-color: #993366; color: #0000ff;\"><span style=\"color: #993366;\">\u03b5\u03c0\u03b9\u03bb\u03bf\u03b3\u03ae \u03ba\u03ad\u03bd\u03c4\u03c1\u03bf\u03c5<\/span><\/span><\/strong><\/li><\/ul><p>An Open-Label, Randomized Phase 3 Study of Linvoseltamab Monotherapy and Linvoseltamab plus Carfilzomib Versus Standard of Care Combination Regimens in Patients with Relapsed\/Refractory Multiple Myeloma, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p><ul><li><strong><span style=\"color: #33cccc;\">MAGNETISMM -032 <span style=\"color: #993366;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span><\/strong><\/li><\/ul><p><span style=\"color: #808080;\">A Phase 3, Open-Label Study of Elranatamab Monotherapy Versus Elotuzumab, Pomalidomide, Dexamethasone (EPd) or Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants with Relapsed\/Refractory Multiple Myeloma Who Received Prior Anti-CD38 Directed Therapy, EU CT number 2023-507871-23-00, <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06152575\">NCT06152575<\/a> \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/span><\/p><ul><li>\u00a0<strong><span style=\"color: #33cccc;\">MAGNETISMM-6\u00a0<\/span><\/strong><strong><span style=\"color: #33cccc;\"><span style=\"color: #993366;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span><\/strong><\/li><\/ul><p>An open-label, 2-arm, multicenter, randomized phase 3 study to evaluate the efficacy and safety of elranatamab (PF-06863135) + daratumumab + lenalidomide versus daratumumab + lenalidomide + dexamethasone in transplant-ineligible participants with newly-diagnosed multiple myeloma\u201d, <a href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT05623020\">NCT05623020<\/a>, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p><ul><li><span style=\"color: #33cccc;\"><strong>MAGNETISMM-7 \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae &#8211; <\/strong><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd\u00a0<\/span><\/span><\/li><\/ul><p>\u039c\u03b9\u03b1 \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, 2 \u03c3\u03ba\u03b5\u03bb\u03ce\u03bd, \u03c6\u03ac\u03c3\u03b7\u03c2 3 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c4\u03bf\u03c5 elranatamab (pf-06863135) \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u03bb\u03b5\u03bd\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03b9\u03b4\u03b7\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03b9\u03c2 \u03bc\u03b5 \u03bd\u03b5\u03bf\u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03b8\u03ad\u03bd \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03c0\u03bf\u03c5 \u03b5\u03b9\u03bd\u03b1\u03b9 \u03b8\u03b5\u03c4\u03b9\u03ba\u03bf\u03af \u03c3\u03c4\u03b7\u03bd \u03b5\u03bb\u03ac\u03c7\u03b9\u03c3\u03c4\u03b7 \u03c5\u03c0\u03bf\u03bb\u03b5\u03b9\u03bc\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03bd\u03cc\u03c3\u03bf \u03b1\u03c6\u03bf\u03cd \u03c5\u03c0\u03bf\u03b2\u03bb\u03b7\u03b8\u03bf\u03cd\u03bd \u03c3\u03b5 \u03b1\u03c5\u03c4\u03cc\u03bb\u03bf\u03b3\u03b7 \u03bc\u03b5\u03c4\u03b1\u03bc\u03cc\u03c3\u03c7\u03b5\u03c5\u03c3\u03b7 \u03b2\u03bb\u03b1\u03c3\u03c4\u03bf\u03ba\u03c5\u03c4\u03c4\u03ac\u03c1\u03c9\u03bd, <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05317416?term=magnetismm&amp;draw=2&amp;rank=5\">NCT05317416<\/a>,\u00a0 \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p><ul><li><strong><span style=\"color: #33cccc;\">EAE115 &#8211; \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae<\/span>\u00a0&#8211; <\/strong><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/li><\/ul><p>\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 2 \u03c4\u03b7\u03c2 \u03b9\u03c3\u03b1\u03c4\u03bf\u03c5\u03be\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u03c0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03a0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03bf\u03cd\u03bd \u039c\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03bb\u03ac\u03b2\u03b5\u03b9 \u03bc\u03af\u03b1 \u03c0\u03c1\u03bf\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03b5\u03af\u03c7\u03b5 \u03bb\u03b5\u03bd\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03b1\u03c3\u03c4\u03bf\u03bb\u03ad\u03b1 \u03c0\u03c1\u03c9\u03c4\u03b5\u03b1\u03c3\u03ce\u03bc\u03b1\u03c4\u03bf\u03c2, <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05298683?term=NCT05298683&amp;draw=2&amp;rank=1\">NCT05298683<\/a> \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p><ul><li><span style=\"color: #33cccc;\"><strong>EAE116 &#8211;<\/strong><\/span>\u00a0<span style=\"color: #ff99cc;\"><strong style=\"caret-color: #33cccc; color: #33cccc;\">\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae<\/strong><span style=\"caret-color: #33cccc; color: #33cccc;\">\u00a0&#8211;<\/span>\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/li><\/ul><p><span style=\"color: #808080;\">\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 2 \u03c4\u03b7\u03c2 \u0399\u03c3\u03b1\u03c4\u03bf\u03c5\u03be\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u0392\u03bf\u03c1\u03c4\u03b5\u03b6\u03bf\u03bc\u03af\u03bc\u03c0\u03b7, \u039a\u03c5\u03ba\u03bb\u03bf\u03c6\u03c9\u03c3\u03c6\u03b1\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u0394\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 \u03b1\u03ba\u03bf\u03bb\u03bf\u03c5\u03b8\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b1\u03c0\u03cc \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c3\u03c5\u03bd\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7\u03c2 \u03bc\u03b5 \u0399\u03c3\u03b1\u03c4\u03bf\u03c5\u03be\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7 \u03ba\u03b1\u03b9 \u039b\u03b5\u03bd\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03c3\u03b5 \u03bd\u03b5\u03bf\u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03b8\u03ad\u03bd\u03c4\u03b5\u03c2 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03bf\u03cd\u03bd \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03ba\u03b1\u03b9 \u03c3\u03bf\u03b2\u03b1\u03c1\u03ae \u03bd\u03b5\u03c6\u03c1\u03b9\u03ba\u03ae \u03b1\u03bd\u03b5\u03c0\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1, <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05147493?term=Hatzimichael&amp;draw=2&amp;rank=1\">NCT05147493<\/a>\u00a0 \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/span><\/p><ul><li><strong><span style=\"color: #33cccc;\">IRACLIA<\/span> <span style=\"color: #33cccc;\">&#8211;<\/span><\/strong><em><span style=\"color: #33cccc;\"><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd\u00a0<\/span><\/span><\/em><\/li><\/ul><p>\u039c\u03b9\u03b1 \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03c6\u03ac\u03c3\u03b7\u03c2 3, \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c3\u03ae\u03bc\u03b1\u03bd\u03c3\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03bd \u03c5\u03c0\u03bf\u03b4\u03cc\u03c1\u03b9\u03b1\u03c2 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u03b5\u03bd\u03b4\u03bf\u03c6\u03bb\u03ad\u03b2\u03b9\u03b1\u03c2 \u03c7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7\u03c2 isatuximab \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u03c0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 \u03c3\u03b5 \u03b5\u03bd\u03ae\u03bb\u03b9\u03ba\u03b5\u03c2 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03b9\u03ac\u03b6\u03bf\u03bd \u03ae\/\u03ba\u03b1\u03b9 \u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 (RRMM),\u00a0 <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05405166\">NCT05405166, <\/a>. \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u039a\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/p><p><span style=\"color: #33cccc;\">MAGNETISMM-5<\/span> &#8211; <span style=\"color: #ff99cc;\"><span style=\"color: #33cccc;\"><strong>\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae<\/strong>\u00a0&#8211;<\/span>\u00a0<em>\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/em><\/span><\/p><p>\u039c\u03b9\u03b1 \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c3\u03ae\u03bc\u03b1\u03bd\u03c3\u03b7\u03c2, \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae, \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 3 \u03c3\u03ba\u03b5\u03bb\u03ce\u03bd \u03c6\u03ac\u03c3\u03b7\u03c2 3 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03bc\u03bf\u03bd\u03bf\u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03bc\u03b5 elranatamab (pf-06863135) \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03bc\u03b5 elranatamab \u03c3\u03c5\u03bd \u03b4\u03b1\u03c1\u03b1\u03c4\u03bf\u03c5\u03bc\u03bf\u03c5\u03bc\u03ac\u03bc\u03c0\u03b7 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u03b4\u03b1\u03c1\u03b1\u03c4\u03bf\u03c5\u03bc\u03bf\u03c5\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03c3\u03c5\u03bd \u03c0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03c3\u03c5\u03bd \u03b4\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 \u03c3\u03b5 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03b9\u03ac\u03b6\u03bf\u03bd\/\u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03bf\u03c5\u03bd \u03bb\u03ac\u03b2\u03b5\u03b9 \u03c4\u03bf\u03c5\u03bb\u03ac\u03c7\u03b9\u03c3\u03c4\u03bf\u03bd 1 \u03c0\u03c1\u03bf\u03b7\u03b3\u03bf\u03c5\u03bc\u03ad\u03bd\u03b7 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2, \u03c3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03b1\u03bd\u03bf\u03bc\u03ad\u03bd\u03b7\u03c2 \u03c4\u03b7\u03c2 \u03bb\u03b5\u03bd\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03bd\u03cc\u03c2 \u03b1\u03bd\u03b1\u03c3\u03c4\u03bf\u03bb\u03ad\u03b1 \u03c0\u03c1\u03c9\u03c4\u03b5\u03b1\u03c3\u03ce\u03bc\u03b1\u03c4\u03bf\u03c2, <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05020236\">NCT05020236<\/a>,\u00a0 \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p><ul><li><strong><span style=\"color: #33cccc;\">DREAMM8 &#8211; GSK207499 &#8211; \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae <\/span><\/strong><em style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/em><\/li><\/ul><p>\u039c\u03b9\u03b1 \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae, \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03ae\u03c2 \u03b5\u03c4\u03b9\u03ba\u03ad\u03c4\u03b1\u03c2, \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 \u0399\u0399\u0399 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03c4\u03bf\u03c5 belantamab mafodotin \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u03c0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 (B-PD) \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03bf\u03c5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03bf\u03cd \u03bc\u03b5 \u03c0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7, \u03b2\u03bf\u03c1\u03c4\u03b5\u03b6\u03bf\u03bc\u03af\u03bc\u03c0\u03b7 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 (PVD) \u03c3\u03b5 \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03b9\u03ac\u03b6\u03bf\u03bd\/\u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1, NCT04484623,\u00a0 \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-9485226\" data-id=\"9485226\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fd22062 elementor-widget elementor-widget-image\" data-id=\"fd22062\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"169\" src=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-300x169.jpeg\" class=\"attachment-medium size-medium wp-image-1841\" alt=\"\" srcset=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-300x169.jpeg 300w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-1024x576.jpeg 1024w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-768x432.jpeg 768w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-1536x864.jpeg 1536w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-2048x1152.jpeg 2048w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-150x85.jpeg 150w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-1920x1080.jpeg 1920w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-600x338.jpeg 600w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-251916311-scaled.jpeg 1440w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-9fa9c80 elementor-widget elementor-widget-spacer\" data-id=\"9fa9c80\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9a84bbf elementor-widget elementor-widget-heading\" data-id=\"9a84bbf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<br><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ebbc334 elementor-widget elementor-widget-spacer\" data-id=\"ebbc334\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5c4b8c1 elementor-widget elementor-widget-text-editor\" data-id=\"5c4b8c1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\"> REALiTEC\/REALiTAL Study<\/span><\/strong><\/li><\/ul><p>A Retrospective, Multicountry Study of Clinical Outcomes in Patients with Relapsed\/Refractory Multiple Myeloma Treated with T-cell Redirectors Outside of Clinical Trials\u202f. <strong>Cohort 2 and Cohort 3<\/strong> Principal Investigator E. Hatzimichael<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5401288 elementor-widget elementor-widget-heading\" data-id=\"5401288\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af<br>\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-45453c2 elementor-widget elementor-widget-spacer\" data-id=\"45453c2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-af71dd0 elementor-widget elementor-widget-text-editor\" data-id=\"af71dd0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>The INSIGHTMM study, A global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients, PI E. Kapsali<\/li><li>20180117 SELECT, \u039c\u03af\u03b1 \u0391\u03bd\u03bf\u03b9\u03c7\u03c4\u03bf\u03cd \u03a3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd, \u03a6\u03ac\u03c3\u03b7\u03c2 2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ae \u03b3\u03b9\u03b1 \u03c4\u03b7 \u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u0391\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03bc\u03b5 \u03a0\u03c1\u03ce\u03c4\u03b7 \u03ae \u0394\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7 \u03a5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03ae \u03a0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03bf\u03cd \u039c\u03c5\u03b5\u03bb\u03ce\u03bc\u03b1\u03c4\u03bf\u03c2 \u03bc\u03b5 \u039a\u03b1\u03c1\u03c6\u03b9\u03bb\u03b6\u03bf\u03bc\u03af\u03bc\u03c0\u03b7, \u03a0\u03bf\u03bc\u03b1\u03bb\u03b9\u03b4\u03bf\u03bc\u03af\u03b4\u03b7 \u03ba\u03b1\u03b9 \u0394\u03b5\u03be\u03b1\u03bc\u03b5\u03b8\u03b1\u03b6\u03cc\u03bd\u03b7 (KPd), \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><li>C16021 &#8211; Tourmaline-MM4 (\u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 \u0399\u0399\u0399), \u03a4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b5\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03bc\u03b5 \u03b5\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03cc \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf, \u03b4\u03b9\u03c0\u03bb\u03ac \u03c4\u03c5\u03c6\u03bb\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 \u0399\u0399\u0399, \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5 \u03c3\u03c4\u03cc\u03bc\u03b1\u03c4\u03bf\u03c2 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b9\u03be\u03b1\u03b6\u03bf\u03bc\u03af\u03bc\u03c0\u03b7, \u03c9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c3\u03c5\u03bd\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bd\u03b5\u03bf\u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03b8\u03ad\u03bd \u03c0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u03bc\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03c0\u03bf\u03c5 \u03b4\u03b5\u03bd \u03ad\u03c7\u03bf\u03c5\u03bd \u03c5\u03c0\u03bf\u03b2\u03bb\u03b7\u03b8\u03b5\u03af \u03c3\u03b5 \u03b1\u03c5\u03c4\u03cc\u03bb\u03bf\u03b3\u03b7 \u03bc\u03b5\u03c4\u03b1\u03bc\u03cc\u03c3\u03c7\u03b5\u03c5\u03c3\u03b7, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03bf\u03b9 \u03ba\u03cd\u03c1\u03b9\u03bf\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2 \u0395. \u039c\u03c0\u03c1\u03b9\u03b1\u03c3\u03bf\u03cd\u03bb\u03b7\u03c2, \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/li><li>Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT &#8211; 1),\u00a0 PI: Prof E. Briasoulis<\/li><li>Phase 3, Randomized, Open Label Trial of Lenalidomide\/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM), PI: Prof E. Briasoulis<\/li><li>A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn\/Dex in Greek Patients With R\/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease (LEGEND), K\u03cd\u03c1\u03b9\u03bf\u03b9 E\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2:\u00a0 \u0395. \u039c\u03c0\u03c1\u03b9\u03b1\u03c3\u03bf\u03cd\u03bb\u03b7\u03c2, \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/li><li>A retrospective chart review and a prospective study of the pomalidomide plus low dose dexamethasone efficacy in relapsed\/refractory Multiple Myeloma patients under real-life conditions, PI E. Kapsali<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9fbb5e7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9fbb5e7\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2062631\" data-id=\"2062631\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ff64359 elementor-widget elementor-widget-heading\" data-id=\"ff64359\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u03a7\u03c1\u03cc\u03bd\u03b9\u03b1 \u039b\u03b5\u03bc\u03c6\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1\n\n<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-110f83e elementor-widget elementor-widget-heading\" data-id=\"110f83e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<br><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5aa0e7e elementor-widget elementor-widget-text-editor\" data-id=\"5aa0e7e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong><span style=\"color: #33cccc;\">&#8220;PRO-SID&#8221; study -\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae <\/span><\/strong>&#8211;\u00a0<span style=\"color: #ff99cc;\"><em><span style=\"color: #33cccc;\"><span style=\"color: #ff99cc;\"> \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7<\/span> <span style=\"color: #ff99cc;\">\u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/span><\/span><\/em><\/span>Double-Blind, Randomized, Placebo-Controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients with Chronic Lymphocytic Leukemia, <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04502030\">NCT04502030<\/a> Primary investigator E. Hatzimichael<\/p><p><span style=\"color: #33cccc;\"><strong>BELLWAVE-011<\/strong><\/span>\u00a0<span style=\"color: #993366;\"><b> NEA &#8211; \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/b><\/span>Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator\u2019s Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma, Primary investigator E. Hatzimichael<\/p><p><span style=\"color: #33cccc;\"><strong>NX-5948-306<\/strong><\/span>\u00a0&#8211; <strong><span style=\"color: #0000ff;\">site selected<\/span><\/strong> A Phase 3, Randomized, Open-label, Multicenter Study of NX-5948 Versus Pirtobrutinib in Relapsed\/Refractory (R\/R) Chronic Lymphocytic Leukemia (CLL)\/Small Lymphocytic Lymphoma (SLL), Primary investigator E. Hatzimichael<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d08a3af elementor-widget elementor-widget-spacer\" data-id=\"d08a3af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96cab1e elementor-widget elementor-widget-heading\" data-id=\"96cab1e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<br><\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4753699 elementor-widget elementor-widget-spacer\" data-id=\"4753699\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-17bcee8 elementor-widget elementor-widget-text-editor\" data-id=\"17bcee8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><span style=\"color: #33cccc;\"><strong>D133FR00166 &#8211; MIRACLLE &#8211; \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae &#8211; <\/strong><em><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <strong><span style=\"color: #333399;\">TOP recruiting center in Greece <\/span><\/strong><\/span><\/em><\/span>\u039c\u03b9\u03b1 \u0395\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae \u03bc\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03bf\u03bf\u03c0\u03c4\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c0\u03b1\u03c1\u03b1\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7\u03c2 \u03b4\u03b9\u03b5\u03c4\u03bf\u03cd\u03c2 \u03b4\u03b9\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03cd\u03c0\u03c9\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03c5\u03c4\u03b9\u03ba\u03ce\u03bd \u03c3\u03c4\u03c1\u03b1\u03c4\u03b7\u03b3\u03b9\u03ba\u03ce\u03bd \u03c0\u03c1\u03ce\u03c4\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2, \u03c4\u03c9\u03bd \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03c5\u03c4\u03b9\u03ba\u03ce\u03bd \u03b5\u03ba\u03b2\u03ac\u03c3\u03b5\u03c9\u03bd, \u03c4\u03b7\u03c2 \u03c0\u03bf\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03b6\u03c9\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03c7\u03c1\u03ae\u03c3\u03b7\u03c2 \u03c0\u03cc\u03c1\u03c9\u03bd \u03c5\u03b3\u03b5\u03af\u03b1\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03a7\u03c1\u03cc\u03bd\u03b9\u03b1 \u039b\u03b5\u03bc\u03c6\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 \u03c3\u03c4\u03b7\u03bd \u039a\u03b1\u03b8\u2019 \u0397\u03bc\u03ad\u03c1\u03b1 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03a0\u03c1\u03ac\u03be\u03b7 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><\/ul><ul><li><span style=\"color: #33cccc;\"><strong>P19-568 &#8211; Concrete &#8211; \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae &#8211; \u00a0&#8211;<\/strong><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/span><\/span>\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03b5\u03ba\u03b2\u03ac\u03c3\u03b5\u03b9\u03c2\u00a0 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03b9\u03ac\u03b6\u03bf\u03c5\u03c3\u03b1\/\u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03ae X\u03c1\u03cc\u03bd\u03b9\u03b1 \u039b\u03b5\u03bc\u03c6\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 (\u03a5\/\u0391 \u03a7\u039b\u039b) \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u03c5\u03c0\u03bf\u03b2\u03ac\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03bc\u03b5 Venetoclax \u03c3\u03b5\u00a0 \u03c3\u03c5\u03bd\u03b8\u03ae\u03ba\u03b5\u03c2 \u03ba\u03b1\u03b8\u03b7\u03bc\u03b5\u03c1\u03b9\u03bd\u03ae\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae\u03c2 \u03c0\u03c1\u03b1\u03ba\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-853161c elementor-widget elementor-widget-heading\" data-id=\"853161c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-06065ff elementor-widget elementor-widget-spacer\" data-id=\"06065ff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-adee64b elementor-widget elementor-widget-text-editor\" data-id=\"adee64b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>A multicentre, open label, single arm, phase IIIb, international study evaluating the safety of Obinutuzumab alone or in combination with chemotherapy in patients with previously untreated or relaprsed\/refractory chronic lymphocytic leukemia, PI E. Briasoulis, E. Kapsali<\/p><p><span style=\"color: #333333;\">H19-476 &#8211; Respire <\/span>\u0391\u03bd\u03b1\u03bb\u03c5\u03c4\u03b9\u03ba\u03ae \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ce\u03bd \u03b5\u03ba\u03b2\u03ac\u03c3\u03b5\u03c9\u03bd \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03bc\u03b5 \u03c5\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03b9\u03ac\u03b6\u03bf\u03c5\u03c3\u03b1\/\u03b1\u03bd\u03b8\u03b5\u03ba\u03c4\u03b9\u03ba\u03ae \u03a7\u03c1\u03cc\u03bd\u03b9\u03b1 \u039b\u03b5\u03bc\u03c6\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 (\u03a5\/\u0391 \u03a7\u039b\u039b) \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u03c5\u03c0\u03bf\u03b2\u03ac\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03b5 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03bc\u03b5 Venetoclax: \u0391\u03bd\u03b1\u03b4\u03c1\u03bf\u03bc\u03b9\u03ba\u03ae \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d6a9412 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d6a9412\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bb693f4\" data-id=\"bb693f4\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4f9b31c elementor-widget elementor-widget-heading\" data-id=\"4f9b31c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039f\u03be\u03b5\u03af\u03b5\u03c2 \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b5\u03c2 (\u03bf\u03be\u03b5\u03af\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b3\u03b5\u03bd\u03ae\u03c2 \u03ba\u03b1\u03b9 \u03bf\u03be\u03b5\u03af\u03b1 \u03bb\u03b5\u03bc\u03c6\u03bf\u03b2\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1)<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4343061 elementor-widget elementor-widget-heading\" data-id=\"4343061\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7c23c90 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7c23c90\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;d88d97e&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-a35f3dd\" data-id=\"a35f3dd\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bbab1cc elementor-widget elementor-widget-text-editor\" data-id=\"bbab1cc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\">Study 75276617AML3001<\/span><\/strong><span style=\"color: #993366;\"><strong> \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/strong><\/span><span style=\"color: #808080;\">A Study of Bleximenib in Combination with VEN+AZA for the Treatment of Participants with Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A or NPM1 Alterations who are ineligible for intensive chemotherapy clinical study, PI E. Hatzimichael<\/span><\/li><\/ul><ul><li><strong><span style=\"color: #33cccc;\">Golden Gate &#8211; 20190360 <span style=\"color: #993366;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/span><\/span><\/strong>\u03a4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u0395\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u0394\u03bf\u03ba\u03b9\u03bc\u03ae \u03a6\u03ac\u03c3\u03b7\u03c2 3 \u03c4\u03b7\u03c2 \u039c\u03c0\u03bb\u03b9\u03bd\u03b1\u03c4\u03bf\u03c5\u03bc\u03bf\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2, \u03a7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u0395\u03bd\u03b1\u03bb\u03bb\u03ac\u03be \u03bc\u03b5 \u03a7\u03b7\u03bc\u03b5\u03b9\u03bf\u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03a7\u03b1\u03bc\u03b7\u03bb\u03ae\u03c2 \u0388\u03bd\u03c4\u03b1\u03c3\u03b7\u03c2, \u0388\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u03a0\u03c1\u03cc\u03c4\u03c5\u03c0\u03b7\u03c2 \u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2, \u03b3\u03b9\u03b1 \u0393\u03b7\u03c1\u03b1\u03b9\u03cc\u03c4\u03b5\u03c1\u03bf\u03c5\u03c2 \u0391\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u039d\u03b5\u03bf\u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03b8\u03b5\u03af\u03c3\u03b1 <strong>\u0391\u03c1\u03bd\u03b7\u03c4\u03b9\u03ba\u03ae \u03b3\u03b9\u03b1 \u03c4\u03bf \u03a7\u03c1\u03c9\u03bc\u03cc\u03c3\u03c9\u03bc\u03b1 Philadelphia \u039f\u03be\u03b5\u03af\u03b1 \u039b\u03b5\u03bc\u03c6\u03bf\u03b2\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ae \u039b\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1<\/strong> \u0395\u03ba \u03a0\u03c1\u03cc\u03b4\u03c1\u03bf\u03bc\u03c9\u03bd \u0392-\u039a\u03c5\u03c4\u03c4\u03ac\u03c1\u03c9\u03bd \u03bc\u03b5 \u03a0\u03c1\u03bf\u03ba\u03b1\u03c4\u03b1\u03c1\u03ba\u03c4\u03b9\u03ba\u03ae \u03a0\u03b5\u03c1\u03af\u03bf\u03b4\u03bf \u0391\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 (\u0394\u03bf\u03ba\u03b9\u03bc\u03ae Golden Gate), <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04994717\">NCT04994717<\/a>, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><\/ul><ul><li><strong><span style=\"color: #33cccc;\">KO-MEN-017<\/span><\/strong> &#8211; \u00a0<span style=\"color: #0000ff;\"><strong>site selection<\/strong><\/span><br \/>Phase 3 Randomized, Double-Blind, Placebo-controlled Studies Assessing Ziftomenib in Combination with Either Standard of Care Nonintensive (Venetoclax + Azacitidine) or Intensive (7+3) Therapy in Patients with Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><\/ul><ul><li><strong><span style=\"color: #33cccc;\"> AMGEN Study 20240113 (AUDAX): <span style=\"color: #0000ff;\">site selection<\/span><\/span><\/strong> \u201cA Phase 3, Open-label, Randomized, Controlled Trial of Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults with Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukaemia\u201d<\/li><\/ul><ul><li><strong><span style=\"color: #33cccc;\">SLSG18-301<\/span> <span style=\"color: #33cccc;\">&#8211;<\/span><\/strong><span style=\"color: #33cccc;\"><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/span><\/span>A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator&#8217;s Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy, <a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04229979?term=SLSG18-301&amp;draw=2&amp;rank=1\">NCT04229979<\/a>, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-d6c36b9\" data-id=\"d6c36b9\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-476f7e0 elementor-widget elementor-widget-image\" data-id=\"476f7e0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"200\" src=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-300x200.jpeg\" class=\"attachment-medium size-medium wp-image-1900\" alt=\"\" srcset=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-300x200.jpeg 300w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-1024x683.jpeg 1024w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-768x512.jpeg 768w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-1536x1024.jpeg 1536w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-2048x1366.jpeg 2048w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-600x400.jpeg 600w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/leukemia-scaled.jpeg 1440w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-9aa1fd8 elementor-widget elementor-widget-heading\" data-id=\"9aa1fd8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3790493 elementor-widget elementor-widget-spacer\" data-id=\"3790493\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4647324 elementor-widget elementor-widget-text-editor\" data-id=\"4647324\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><span style=\"color: #33cccc;\"><strong>\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 SECURE &#8211;<\/strong><span style=\"color: #ff99cc;\"><em>\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/em><\/span><\/span><span style=\"color: #ff99cc;\"><em>\u00a0<\/em><\/span> \u03a0\u03c1\u03cc\u03c4\u03c5\u03c0\u03b1 \u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c3\u03b5 \u03a0\u03c1\u03b1\u03b3\u03bc\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 \u03a3\u03c5\u03bd\u03b8\u03ae\u03ba\u03b5\u03c2 \u03ba\u03b1\u03b9 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0395\u03ba\u03b2\u03ac\u03c3\u03b5\u03b9\u03c2 \u03c3\u03b5 \u039c\u03b7 \u039a\u03b1\u03c4\u03ac\u03bb\u03bb\u03b7\u03bb\u03bf\u03c5\u03c2 \u0391\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u039f\u039c\u039b \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1 \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u039b\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03a0\u03c1\u03ce\u03c4\u03b7\u03c2 \u0393\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 \u03a3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03ae \u03c4\u03b7\u03bd \u039a\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03b7 \u03a5\u03c0\u03bf\u03c3\u03c4\u03b7\u03c1\u03b9\u03ba\u03c4\u03b9\u03ba\u03ae \u03a6\u03c1\u03bf\u03bd\u03c4\u03af\u03b4\u03b1\u00bb, Sponsor: AbbVie<\/li><li><strong><span style=\"color: #33cccc;\">\u039c\u03b5\u03bb\u03ad\u03c4\u03b7 SURVIVE <\/span><\/strong><span style=\"color: #33cccc;\"><span style=\"color: #ff99cc;\"><span style=\"caret-color: #33cccc; color: #33cccc; text-align: justify;\">\u00a0&#8211;<\/span>\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span><span style=\"color: #ff99cc;\">\u00a0<\/span> \u03a0\u03c1\u03bf\u03bf\u03c0\u03c4\u03b9\u03ba\u03ae \u03bc\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ae \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03c9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c0\u03c1\u03ce\u03c4\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bf\u03be\u03b5\u03af\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b5\u03b9\u03b4\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 (\u039f\u039c\u039b) \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u03b4\u03b5\u03bd \u03b5\u03af\u03bd\u03b1\u03b9 \u03ba\u03b1\u03c4\u03ac\u03bb\u03bb\u03b7\u03bb\u03bf\u03b9 \u03b3\u03b9\u03b1 \u03b5\u03bd\u03c4\u03b1\u03c4\u03b9\u03ba\u03ae \u03c7\u03b7\u03bc\u03b5\u03b9\u03bf\u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03c3\u03c4\u03b7 \u03c3\u03c5\u03bd\u03ae\u03b8\u03b7 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03c0\u03c1\u03b1\u03ba\u03c4\u03b9\u03ba\u03ae \u03c3\u03c4\u03b7\u03bd \u0395\u03bb\u03bb\u03ac\u03b4\u03b1\u00bb, Sponsor: AbbVie<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2bdfd52 elementor-widget elementor-widget-heading\" data-id=\"2bdfd52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7ac7282 elementor-widget elementor-widget-spacer\" data-id=\"7ac7282\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d783524 elementor-widget elementor-widget-text-editor\" data-id=\"d783524\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>ASPER-III-19-1, <\/strong>M\u03af\u03b1 \u03c6\u03ac\u03c3\u03b7\u03c2 3, \u03b4\u03b9\u03c0\u03bb\u03ae-\u03c4\u03c5\u03c6\u03bb\u03ae, \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae, \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b5\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03bc\u03b5 \u03b5\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03cc \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2, \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2\u00a0 \u03b1\u03bd\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03b5\u03b9\u03c3\u03c0\u03bd\u03b5\u03cc\u03bc\u03b5\u03bd\u03b7\u03c2 \u03b9\u03c4\u03c1\u03b1\u03ba\u03bf\u03bd\u03b1\u03b6\u03cc\u03bb\u03b7\u03c2 \u03c3\u03b5 \u03bc\u03bf\u03c1\u03c6\u03ae \u03be\u03b7\u03c1\u03ac\u03c2 \u03ba\u03cc\u03bd\u03b5\u03c9\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd\u00a0 \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7 \u03c4\u03b7\u03c2 \u03b4\u03b9\u03b7\u03b8\u03b7\u03c4\u03b9\u03ba\u03ae\u03c2 \u03bc\u03c5\u03ba\u03b7\u03c4\u03b9\u03b1\u03c3\u03b9\u03ba\u03ae\u03c2 \u03bb\u03bf\u03af\u03bc\u03c9\u03be\u03b7\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bf\u03be\u03b5\u03af\u03b1 \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 \u03ba\u03b1\u03b9 \u03bf\u03c5\u03b4\u03b5\u03c4\u03b5\u03c1\u03bf\u03c0\u03b5\u03bd\u03af\u03b1, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><li><strong>POLO-AML:<\/strong> A phase III randomised, double-blind, controlled, parallel group study of intravenous volasertib in combination with subcutaneous low-dose cytarabine vs. placebo + low-dose cytarabine in patients \u2265 65 years with previously untreated acute myeloid leukaemia, who are ineligible for intensive remission induction therapy,\u00a0 PI: Prof E. Briasoulis<\/li><li><strong>TOWER: <\/strong>Phase 3 Trial of Blinatumomab vs Investigator&#8217;s Choice of Chemotherapy in Patients With Relapsed or Refractory ALL, Sponsor: Amgen, PI: Prof E. Briasoulis<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bc2cb20 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bc2cb20\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4792289\" data-id=\"4792289\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-bb0a848 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bb0a848\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;6b7d504&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-b93006d\" data-id=\"b93006d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c8cf064 elementor-widget elementor-widget-heading\" data-id=\"c8cf064\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 Hodgkin \u039b\u03b5\u03bc\u03c6\u03ce\u03bc\u03b1\u03c4\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0196f0c elementor-widget elementor-widget-heading\" data-id=\"0196f0c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-1ac73a1 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1ac73a1\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;d88d97e&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-49513d1\" data-id=\"49513d1\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2019d42 elementor-widget elementor-widget-text-editor\" data-id=\"2019d42\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><p><strong><span style=\"color: #33cccc;\">ARCHED\/GLA 2022-1 <span style=\"color: #993366;\">open for enrollment <\/span><\/span><\/strong><\/p><\/li><\/ul><p>A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituxima and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma\u00bb. Principal Investigator E. Hatzimichael<\/p><ul><li><strong><span style=\"color: #33cccc;\">GOLSEEK-4 <span style=\"color: #993366;\">open for enrollment<\/span><\/span><\/strong><\/li><\/ul><p>A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator\u2019s Choice in Participants with Relapsed\/Refractory Follicular Lymphoma, Principal Investigator E. Hatzimichael<\/p><ul><li><span style=\"color: #33cccc;\">GOLSEEK-1<\/span> <strong><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7\u00a0\u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/strong><br \/>A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants With Previously Untreated High-risk Large B-cell Lymphoma, NCT06356129, Principal Investigator E. Hatzimichael<\/li><li><span style=\"color: #33cccc;\"><strong> EXS73565-001 <span style=\"color: #0000ff;\">site selected<\/span><\/strong><\/span><\/li><\/ul><p>A Phase 1 open-label, multicenter, dose escalation study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of EXS73565 in participants with relapsed or refractory B-cell malignancies<\/p><ul><li><span style=\"color: #33cccc;\"><strong>EPCORETM FL-1 &#8211;<\/strong><\/span> <span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/li><\/ul><p>A Phase 3, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in Subjects with Relapsed or Refractory Follicular Lymphoma, <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05409066?term=epcore+fl-1&amp;draw=2&amp;rank=1\">NCT05409066<\/a>, Principal Investigator E. Hatzimichael<\/p><p>\u03a0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 <a href=\"https:\/\/www.klinikesmeletes.com\/conditions\/\u03b4\u03b9\u03ac\u03c7\u03c5\u03c4\u03bf-\u03b1\u03c0\u03cc-b-\u03bc\u03b5\u03b3\u03ac\u03bb\u03b1-\u03ba\u03cd\u03c4\u03c4\u03b1\u03c1\u03b1-\u03bb\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1\/\">\u03b5\u03b4\u03ce<\/a><\/p><ul><li><strong><span style=\"color: #33cccc;\">EPCORE \u039c20-621 &#8211;<\/span><\/strong><span style=\"color: #33cccc;\"><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span><\/li><\/ul><p>A Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination w\/ R-CHOP Compared to R-CHOP in Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL), <a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05578976?term=epcore+m20-621&amp;draw=2&amp;rank=1\">NCT05578976<\/a>, Principal Investigator E. Hatzimichael<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-7d24d3d\" data-id=\"7d24d3d\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-049aef2 elementor-widget elementor-widget-image\" data-id=\"049aef2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"169\" src=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-300x169.jpeg\" class=\"attachment-medium size-medium wp-image-2169\" alt=\"\" srcset=\"https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-300x169.jpeg 300w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-1024x576.jpeg 1024w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-768x432.jpeg 768w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-1536x864.jpeg 1536w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-2048x1152.jpeg 2048w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-150x85.jpeg 150w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-1920x1080.jpeg 1920w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-600x338.jpeg 600w, https:\/\/haematology.med.uoi.gr\/wp-content\/uploads\/2021\/11\/adobestock-176621722-scaled.jpeg 1440w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-d659864 elementor-widget elementor-widget-spacer\" data-id=\"d659864\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8d44c8c elementor-widget elementor-widget-heading\" data-id=\"8d44c8c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ccab6bd elementor-widget elementor-widget-spacer\" data-id=\"ccab6bd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-075d2af elementor-widget elementor-widget-text-editor\" data-id=\"075d2af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\"> EpcoReal &#8211; \u03b5\u03bd\u03b5\u03c1\u03b3\u03ae- <\/span><\/strong>: \u039c\u03b9\u03b1 \u03c0\u03bf\u03bb\u03c5\u03b5\u03b8\u03bd\u03b9\u03ba\u03ae, \u03c0\u03c1\u03bf\u03bf\u03c0\u03c4\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c0\u03b1\u03c1\u03b1\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 epcoritamab \u03c3\u03c4\u03bf \u039c\u03b7 Hodgkin \u039b\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 (NHL) \u03c0\u03bf\u03c5 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03b4\u03cd\u03bf \u03ba\u03bf\u03cc\u03c1\u03c4\u03b5\u03b9\u03c2 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd [\u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 (\u03b4\u03b9\u03ac\u03c7\u03c5\u03c4\u03bf) \u03bb\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 \u03b1\u03c0\u03cc \u03bc\u03b5\u03b3\u03ac\u03bb\u03b1 \u0392-\u03ba\u03cd\u03c4\u03c4\u03b1\u03c1\u03b1 \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 2\u03b7\u03c2 \u03ae\/\u03ba\u03b1\u03b9 \u03bc\u03b5\u03c4\u03b1\u03b3\u03b5\u03bd\u03ad\u03c3\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 (3L+ [D]LBCL) \u03ba\u03b1\u03b9 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bf\u03b6\u03ce\u03b4\u03b5\u03c2 \u03bb\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 \u03c0\u03bf\u03c5 \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 2\u03b7\u03c2 \u03ae\/\u03ba\u03b1\u03b9 \u03bc\u03b5\u03c4\u03b1\u03b3\u03b5\u03bd\u03ad\u03c3\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 (3L+ FL)], \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cc74368 elementor-widget elementor-widget-heading\" data-id=\"cc74368\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ccfbd97 elementor-widget elementor-widget-spacer\" data-id=\"ccfbd97\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-92c62a6 elementor-widget elementor-widget-text-editor\" data-id=\"92c62a6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>MCL3004 &#8211; VEGA<\/strong> \u00a0A Randomized, Controlled, Open-label, Multicenter, Inferentially Seamless Phase 2\/Phase 3 Study of the Bruton\u2019s Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Combination with Rituximab Versus Physician\u2019s Choice of Lenalidomide Plus Rituximab or Bortezomib Plus Rituximab in Participants with Relapsed or Refractory Mantle Cell Lymphoma who are BTK inhibitor-na\u00efve, PI E. Hatzimichael<\/li><li><strong>SADAL<\/strong> A Phase 2b Open-label Study of Selinexor (KPT\u2011330) in Patients with Relapsed\/Refractory Diffuse Large B-Cell Lymphoma (DLBCL). Principal Investigator: E. Kapsali<\/li><li><strong>The COASTAL Study, <\/strong>A Phase 3, Randomized, Open-Label, Controlled, Multicenter Study of Zandelisib (ME-401) in Combination with Rituximab Versus Standard Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin\u2019s Lymphoma (iNHL), Principal Investigator: E. Kapsali<\/li><li><strong>PCYC -1143-CA<\/strong>,\u00a0 \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03a6\u03ac\u03c3\u03b7\u03c2 3 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b9\u03bc\u03c0\u03c1\u03bf\u03c5\u03c4\u03b9\u03bd\u03af\u03bc\u03c0\u03b7 \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u03c4\u03b7 \u03b2\u03b5\u03bd\u03b5\u03c4\u03bf\u03ba\u03bb\u03ac\u03be\u03b7 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bb\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 \u03b1\u03c0\u03cc \u03ba\u03cd\u03c4\u03c4\u03b1\u03c1\u03b1 \u03c4\u03bf\u03c5 \u03bc\u03b1\u03bd\u03b4\u03cd\u03b1, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1\u00a0 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/li><li><strong>ACE-LY-308<\/strong>, \u039c\u03af\u03b1 \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u0394\u03b9\u03c0\u03bb\u03ac \u03a4\u03c5\u03c6\u03bb\u03ae \u039c\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u0391\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u0391\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2, \u03c4\u03b7\u03c2 \u0391\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u0391\u03bd\u03bf\u03c3\u03bf\u03b3\u03bf\u03bd\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 ABP 798 \u03c3\u03b5 \u03a3\u03cd\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03bc\u03b5 \u03a1\u03b9\u03c4\u03bf\u03c5\u03be\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7, \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u039b\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 \u039c\u03b7 Hodgkin (NHL) B \u03ba\u03c5\u03c4\u03c4\u03ac\u03c1\u03c9\u03bd \u03b8\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03b3\u03b9\u03b1 CD20, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1\u00a0 \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/li><li><strong>20130109<\/strong>, \u039c\u03b9\u03b1 \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b4\u03b9\u03c0\u03bb\u03ac \u03c4\u03c5\u03c6\u03bb\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 3 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2, \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03b3\u03bf\u03bd\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 ABP 798 \u03c3\u03b5 \u03c3\u03cd\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03bc\u03b5 \u03c1\u03b9\u03c4\u03bf\u03c5\u03be\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7, \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u039b\u03ad\u03bc\u03c6\u03c9\u03bc\u03b1 \u03bc\u03b7 Hodgkin (NHL) B-\u03ba\u03c5\u03c4\u03c4\u03ac\u03c1\u03c9\u03bd CD20+, \u039a\u03cd\u03c1\u03b9\u03bf\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2 \u0395. \u039c\u03c0\u03c1\u03b9\u03b1\u03c3\u03bf\u03cd\u03bb\u03b7\u03c2, \u0395. \u039a\u03b1\u03c8\u03ac\u03bb<\/li><li><strong>PILLAR 2 Study<\/strong>, A randomized, double-blind, placebo-controlled, multicenter phase III study of RAD001 adjuvant therapy in poor risk patients with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching placebo after patients have achieved complete response with first-line rituximab- chemotherapy, PI: Prof E. Briasoulis<\/li><li><strong>ASSIST-FL<\/strong>, GP2013 in the Treatment of Patients with Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL),\u00a0 PI: Prof E. Briasoulis<\/li><li>Mabease, A comparative, randomized, parallel-group, multi-center, Phase IIIB Study to Investigate the Efficacy of Subcutaneous (SC) Rituximab Versus Intravenous (IV) Rituximab Both in Combination With CHOP (R-CHOP) in Previously Untreated Patients With CD20-positive Diffuse Large B-cell Lymphoma (DLBCL), , PI: Prof E. Briasoulis<\/li><li><strong>Mabcute<\/strong>, A Study Comparing Maintenance Subcutaneous MabThera\/Rituxan (Rituximab) With Observation Only in Patients With Relapsed or Refractory Indolent Non-Hodgkin&#8217;s Lymphoma Who Had Responded to MabThera-Based Immunochemotherapy Induction and Two Years of Maintenance With Subcutaneous MabThera, PI: Prof E. Briasoulis<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b71c4b5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b71c4b5\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e265da1\" data-id=\"e265da1\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-43ff5dd elementor-widget elementor-widget-heading\" data-id=\"43ff5dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039c\u03c5\u03b5\u03bb\u03bf\u03b4\u03c5\u03c3\u03c0\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ac \u03a3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-94784f0 elementor-widget elementor-widget-heading\" data-id=\"94784f0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bf217f3 elementor-widget elementor-widget-text-editor\" data-id=\"bf217f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\"> TAK-226-3001 &#8211; <span style=\"color: #3366ff;\">site selection<\/span><\/span><\/strong><\/li><\/ul><p>A Phase 3, Multicenter, Open Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-na\u00efve Adult Participants Who Require Red Blood Cell Transfusions &#8211; PI E. Hatzimichael<\/p><ul><li><strong><span style=\"color: #33cccc;\">\u00a0P-SP420-THAL-01 \u00a0&#8211; <span style=\"color: #993366;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span><\/strong><\/li><\/ul><p>An open-label, dose-escalation, dose-finding, and proof-of-concept trial\u00a0of SP-420 in subjects with transfusion-dependent \u03b1- or \u03b2- thalassemia or low-risk myelodysplastic syndromes, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cac4042 elementor-widget elementor-widget-heading\" data-id=\"cac4042\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e2f52b0 elementor-widget elementor-widget-text-editor\" data-id=\"e2f52b0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\">\u00a0MURAL\u00a0 &#8211; <\/span><\/strong><span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/li><\/ul><p>Multi-country Real World Study to explore treatment patterns, clinical outcomes, and healthcare resource utilization in patients with MDS\/AML per ICC 2022 criteria, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6898534 elementor-widget elementor-widget-heading\" data-id=\"6898534\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f61c5ce elementor-widget elementor-widget-spacer\" data-id=\"f61c5ce\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a16260b elementor-widget elementor-widget-text-editor\" data-id=\"a16260b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>MBG453<\/strong>, \u00a0\u03a4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b4\u03b9\u03c0\u03bb\u03ac-\u03c4\u03c5\u03c6\u03bb\u03ae, \u03b5\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03bc\u03b5 \u03b5\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03cc \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 \u0399\u0399\u0399 \u03c4\u03b7\u03c2 \u03b1\u03b6\u03b1\u03ba\u03b9\u03c4\u03b9\u03b4\u03af\u03bd\u03b7\u03c2 \u03bc\u03b5 \u03ae \u03c7\u03c9\u03c1\u03af\u03c2 MBG453 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03bc\u03b5 \u03b5\u03bd\u03b4\u03b9\u03ac\u03bc\u03b5\u03c3\u03bf\u03c5, \u03c5\u03c8\u03b7\u03bb\u03bf\u03cd \u03ae \u03c0\u03bf\u03bb\u03cd \u03c5\u03c8\u03b7\u03bb\u03bf\u03cd \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b4\u03c5\u03c3\u03c0\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf (\u039c\u0394\u03a3) \u03c3\u03cd\u03bc\u03c6\u03c9\u03bd\u03b1 \u03bc\u03b5 \u03c4\u03b1 \u03ba\u03c1\u03b9\u03c4\u03ae\u03c1\u03b9\u03b1 IPSS-R, \u03ae \u03bc\u03b5 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03bc\u03bf\u03bd\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1-2 (CMML-2), \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/li><li><strong>Pevonedistat-3001, <\/strong>\u039c\u03af\u03b1 \u03c6\u03ac\u03c3\u03b7\u03c2 3, \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b5\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7, \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae\u03c2 \u03b5\u03c0\u03b9\u03c3\u03ae\u03bc\u03b1\u03bd\u03c3\u03b7\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c4\u03bf\u03c5 Pevonedistat \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03b1\u03c3\u03bc\u03cc \u03bc\u03b5 \u03b1\u03b6\u03b1\u03ba\u03b9\u03c4\u03b9\u03b4\u03af\u03bd\u03b7 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03bc\u03bf\u03bd\u03bf\u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03bc\u03b5 \u03b1\u03b6\u03b1\u03ba\u03b9\u03c4\u03b9\u03b4\u03af\u03bd\u03b7 \u03c9\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c0\u03c1\u03ce\u03c4\u03b7\u03c2 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae\u03c2 \u03b3\u03b9\u03b1 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03bf\u03c5 \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03bf\u03c5 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b4\u03c5\u03c3\u03c0\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ac \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03b1, \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03bc\u03bf\u03bd\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03b9\u03ba\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 \u03ae \u03bf\u03be\u03b5\u03af\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b3\u03b5\u03bd\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 \u03bc\u03b5 \u03c7\u03b1\u03bc\u03b7\u03bb\u03cc \u03c0\u03bf\u03c3\u03bf\u03c3\u03c4\u03cc \u03b2\u03bb\u03b1\u03c3\u03c4\u03ce\u03bd, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/li><li><strong>TELESTO, <\/strong>A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial of Deferasirox in Patients With Myelodysplastic Syndromes (Low\/Int-1 Risk) and Transfusional Iron Overload. , PI: Prof E. Briasoulis<\/li><li><strong>ASPIRE, <\/strong>A Three-part Study of Eltrombopag in Thrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid (Part 1: open-label, Part 2: randomized, double-blind, Part 3: extension) -ASPIRE: A Study of Eltrompobag In Myelodysplastic SyndRomes and AcutE Myeloid Leukemia\u201d, PI: Prof E. Briasoulis<\/li><li><strong>ARCADE, <\/strong>A Multicenter, Randomised, Double-blind, Placebo-controlled Study of Darbepoetin Alfa for the Treatment of Anaemic Subjects with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS), Sponsor: Amgen, PI: Prof E. Briasoulis<\/li><li><strong>CC-5013-PASS 001, <\/strong>A non intervational observational post authorization safety study of subjects treated with lenalidomide\u201d, \u03a6\u03bf\u03c1\u03ad\u03b1\u03c2: Genesis Pharma SA-Gelgene, \u0395\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03bf\u03b9 \u03ba\u03cd\u03c1\u03b9\u03bf\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2, \u0395. \u039c\u03c0\u03c1\u03b9\u03b1\u03c3\u03bf\u03cd\u03bb\u03b7\u03c2, \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-98f7c22 elementor-widget elementor-widget-spacer\" data-id=\"98f7c22\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-64b8d71 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"64b8d71\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-598bffd\" data-id=\"598bffd\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-79c44e8 elementor-widget elementor-widget-heading\" data-id=\"79c44e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039d\u03c5\u03ba\u03c4\u03b5\u03c1\u03b9\u03bd\u03ae \u03a0\u03b1\u03c1\u03bf\u03be\u03c5\u03bd\u03c4\u03b9\u03ba\u03ae \u0391\u03b9\u03bc\u03bf\u03c6\u03b1\u03b9\u03c1\u03b9\u03bd\u03bf\u03c5\u03c1\u03af\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b8ab80 elementor-widget elementor-widget-spacer\" data-id=\"2b8ab80\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3ad038c elementor-widget elementor-widget-heading\" data-id=\"3ad038c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8955775 elementor-widget elementor-widget-text-editor\" data-id=\"8955775\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><p><strong>BO42162\u00a0<\/strong>\u039c\u03af\u03b1 \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03ae\u03c2 \u03b5\u03c4\u03b9\u03ba\u03ad\u03c4\u03b1\u03c2, \u03b5\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03bc\u03b5 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b9\u03ba\u03cc \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf, \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7\u03c2 \u0399\u0399\u0399 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03c4\u03b7\u03c2 \u039a\u03c1\u03bf\u03b2\u03b1\u03bb\u03b9\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u0395\u03ba\u03bf\u03c5\u03bb\u03b9\u03b6\u03bf\u03c5\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03c3\u03b5 \u03b5\u03bd\u03ae\u03bb\u03b9\u03ba\u03bf\u03c5\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03c6\u03ae\u03b2\u03bf\u03c5\u03c2 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03c0\u03b1\u03c1\u03bf\u03be\u03c5\u03c3\u03bc\u03b9\u03ba\u03ae \u03bd\u03c5\u03ba\u03c4\u03b5\u03c1\u03b9\u03bd\u03ae \u03b1\u03b9\u03bc\u03bf\u03c3\u03c6\u03b1\u03b9\u03c1\u03b9\u03bd\u03bf\u03c5\u03c1\u03af\u03b1 (\u03a0\u039d\u0391) \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u03b4\u03b5\u03bd \u03ad\u03c7\u03bf\u03c5\u03bd \u03bb\u03ac\u03b2\u03b5\u03b9 \u03c0\u03c1\u03bf\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03bc\u03b5 \u03b1\u03bd\u03b1\u03c3\u03c4\u03bf\u03bb\u03b5\u03af\u03c2 \u03c4\u03bf\u03c5 \u03c3\u03c5\u03bc\u03c0\u03bb\u03b7\u03c1\u03ce\u03bc\u03b1\u03c4\u03bf\u03c2, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-401b1d2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"401b1d2\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b21f820\" data-id=\"b21f820\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ba7c3ee elementor-widget elementor-widget-heading\" data-id=\"ba7c3ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u0399\u03b4\u03b9\u03bf\u03c0\u03b1\u03b8\u03ae\u03c2 \u03b8\u03c1\u03bf\u03bc\u03b2\u03bf\u03c0\u03b5\u03bd\u03b9\u03ba\u03ae \u03a0\u03bf\u03c1\u03c6\u03cd\u03c1\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c90598f elementor-widget elementor-widget-heading\" data-id=\"c90598f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b35c32d elementor-widget elementor-widget-spacer\" data-id=\"b35c32d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4d5d03f elementor-widget elementor-widget-text-editor\" data-id=\"4d5d03f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"color: #33cccc;\"><strong> TNT119-ITP-201<\/strong><\/span> &#8211; <span style=\"color: #993366;\"><strong>\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/strong><\/span><\/p><p>A Phase 1b\/2a, Open-Label, Sequential-Cohort, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Effectiveness of Budoprutug (TNT119) in Subjects with Immune Thrombocytopenia (ITP), PI E. Hatzimichael<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cd9c520 elementor-widget elementor-widget-heading\" data-id=\"cd9c520\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d77959b elementor-widget elementor-widget-text-editor\" data-id=\"d77959b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>myOpportunITy study TP0003, <\/strong>\u039c\u03af\u03b1 \u03a6\u03ac\u03c3\u03b7\u03c2 3 \u03a0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae, \u0394\u03b9\u03c0\u03bb\u03ac-\u03a4\u03c5\u03c6\u03bb\u03ae, \u03a4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7, \u0395\u03bb\u03b5\u03b3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03bc\u03b5 \u0395\u03b9\u03ba\u03bf\u03bd\u03b9\u03ba\u03cc \u03a6\u03ac\u03c1\u03bc\u03b1\u03ba\u03bf \u0394\u03bf\u03ba\u03b9\u03bc\u03ae \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u0391\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u0391\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2, \u03c4\u03b7\u03c2 \u0391\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u0391\u03bd\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03a1\u03bf\u03b6\u03b1\u03bd\u03bf\u03bb\u03b9\u03be\u03b9\u03b6\u03bf\u03c5\u03bc\u03ac\u03bc\u03c0\u03b7\u03c2 \u03c3\u03b5 \u0395\u03bd\u03b7\u03bb\u03af\u03ba\u03bf\u03c5\u03c2 \u03a3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03bf\u03bd\u03c4\u03b5\u03c2 \u03c3\u03c4\u03b7 \u0394\u03bf\u03ba\u03b9\u03bc\u03ae \u03bc\u03b5 \u0395\u03bc\u03bc\u03ad\u03bd\u03bf\u03c5\u03c3\u03b1 \u03ae \u03a7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03a0\u03c1\u03c9\u03c4\u03bf\u03c0\u03b1\u03b8\u03ae \u0391\u03c5\u03c4\u03bf\u03ac\u03bd\u03bf\u03c3\u03b7 \u0398\u03c1\u03bf\u03bc\u03b2\u03bf\u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03bf\u03c0\u03b5\u03bd\u03af\u03b1 (\u0399\u0398\u03a0), \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 (Principal Investigator) \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb, \u0395\u03c0. \u039a\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1dfdbbf elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1dfdbbf\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3de4193\" data-id=\"3de4193\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e506218 elementor-widget elementor-widget-heading\" data-id=\"e506218\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b5\u03c3\u03bf\u03b3\u03b5\u03b9\u03b1\u03ba\u03ae \u03b1\u03bd\u03b1\u03b9\u03bc\u03af\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2293512 elementor-widget elementor-widget-spacer\" data-id=\"2293512\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c5a02f8 elementor-widget elementor-widget-heading\" data-id=\"c5a02f8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c61667f elementor-widget elementor-widget-text-editor\" data-id=\"c61667f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>ENERGIZE A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non\u2013Transfusion-Dependent Alpha- or Beta-Thalassemia, PI E. Kapsali<\/li><li>ENERGIZE-T \u00a0A Phase 3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia , PI E. Kapsali<\/li><li>A nationwide, epidemiological, retrospective cross-sectional study to capture the real- world complication burden, associated hospital resource utilization, and disease management paradigms and to identify determinants of complications in transfusion- dependent Beta-Thalassemia adults in Greece, PI E. Kapsali<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e494787 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e494787\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;36eccb2&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bab9942\" data-id=\"bab9942\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a3d431f elementor-widget elementor-widget-heading\" data-id=\"a3d431f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">\u039c\u03c5\u03b5\u03bb\u03bf\u03cb\u03c0\u03b5\u03c1\u03c0\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ac \u039d\u03b5\u03bf\u03c0\u03bb\u03ac\u03c3\u03bc\u03b1\u03c4\u03b1<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0cf5ce3 elementor-widget elementor-widget-heading\" data-id=\"0cf5ce3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b58a488 elementor-widget elementor-widget-spacer\" data-id=\"b58a488\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4914963 elementor-widget elementor-widget-text-editor\" data-id=\"4914963\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\">KRT-232-115<\/span><\/strong> <span style=\"color: #993366;\"><strong>NEA \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/strong> <\/span>A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Navtemadlin Plus Ruxolitinib Versus Placebo Plus Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post-ET-MF) That Have a Suboptimal Response to Ruxolitinib<\/li><li><strong><span style=\"color: #33cccc;\">XPORT-MF-044<\/span> <span style=\"color: #993366;\">NEA \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/strong> A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor-na\u00efve myelofibrosis and moderate thrombocytopenia, Sponsor Kariopharm Therapeutics Inc, EUCT number:<a href=\"https:\/\/euclinicaltrials.eu\/search-for-clinical-trials\/?lang=en&amp;EUCT=2024-511309-47-00\">2024-511309-47-00<\/a>, PI E. Hatzimichael<\/li><li><strong><span style=\"color: #33cccc;\">XPORT-MF-034 <span style=\"color: #993366;\">NEA<\/span> <span style=\"color: #993366;\">\u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ae \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd <\/span><\/span><\/strong><span style=\"color: #808080;\">A phase 1\/3 study to evaluate the efficacy and safety of selinexor, a selective inhibitor of nuclear export, in combination with ruxolitinib in treatment-nai\u0308ve patients with myelofibrosis, \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04562389\">NCT04562389<\/a> <a href=\"https:\/\/euclinicaltrials.eu\/search-for-clinical-trials\/?lang=en&amp;EUCT=2023-506139-13-00\">EUCT number: 2023-506139-13-00, <\/a>\u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb\u00a0<\/span><\/li><li><strong><span style=\"color: #33cccc;\">CABL001J12302\u00a0<span style=\"font-weight: 400; color: #ff99cc;\"><strong style=\"caret-color: #33cccc; color: #33cccc; font-size: 14px; text-align: justify;\">\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae<\/strong><span style=\"caret-color: #33cccc; color: #33cccc; font-size: 14px; text-align: justify;\">\u00a0&#8211;<\/span>\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span>\u00a0<\/span><\/strong>\u039c\u03af\u03b1 \u03c6\u03ac\u03c3\u03b7\u03c2 IIIb, \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae, \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03ae, \u03c4\u03c5\u03c7\u03b1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03b7 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03bd\u03b5\u03ba\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5 \u03c3\u03c4\u03cc\u03bc\u03b1\u03c4\u03bf\u03c2 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03bf\u03c5 asciminib \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u03bd\u03b9\u03bb\u03bf\u03c4\u03b9\u03bd\u03af\u03bc\u03c0\u03b7\u03c2 \u03c3\u03b5 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03bd\u03b5\u03bf\u03b4\u03b9\u03b1\u03b3\u03bd\u03c9\u03c3\u03bc\u03ad\u03bd\u03b7 \u03b8\u03b5\u03c4\u03b9\u03ba\u03ae \u03c3\u03c4\u03bf \u03c7\u03c1\u03c9\u03bc\u03cc\u03c3\u03c9\u03bc\u03b1 \u03c4\u03b7\u03c2 \u03a6\u03b9\u03bb\u03b1\u03b4\u03ad\u03bb\u03c6\u03b5\u03b9\u03b1\u03c2 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03bc\u03c5\u03b5\u03bb\u03bf\u03b3\u03b5\u03bd\u03ae \u03bb\u03b5\u03c5\u03c7\u03b1\u03b9\u03bc\u03af\u03b1 \u03c3\u03b5 \u03c7\u03c1\u03cc\u03bd\u03b9\u03b1 \u03c6\u03ac\u03c3\u03b7, <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05456191\">NCT05456191<\/a> \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u039a\u03cd\u03c1\u03b9\u03b1 \u0395\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395. \u039a\u03b1\u03c8\u03ac\u03bb\u03b7<\/li><li><span style=\"color: #000000;\"><span style=\"color: #33cccc;\"><strong>KRT-232-101<\/strong> <span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span><\/span>\u00a0<span style=\"color: #808080;\">A Phase 2\/3 Randomized, Controlled, Open-Label Study of KRT-232 in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post-ET-MF) who are Relapsed or Refractory to Janus Kinase (JAK) Inhibitor Treatment, <a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03662126\">NCT03662126<\/a> PI E. Hatzimichael<\/span><\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-211fdbf elementor-widget elementor-widget-heading\" data-id=\"211fdbf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">\u039c\u03b7 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f33d755 elementor-widget elementor-widget-text-editor\" data-id=\"f33d755\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong><span style=\"color: #33cccc;\">METER<\/span><\/strong> <span style=\"color: #ff99cc;\">\u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd<\/span> A Multi-Country, Real-World Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients Diagnosed with Myelofibrosis through Chart Review, Principal Investigator, E. Hatzimichael<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-75acf96 elementor-widget elementor-widget-heading\" data-id=\"75acf96\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">\u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u0394\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03ae \u03ad\u03c7\u03bf\u03c5\u03bd \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03c9\u03b8\u03b5\u03af\n\n<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-44e37e1 elementor-widget elementor-widget-spacer\" data-id=\"44e37e1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8378618 elementor-widget elementor-widget-text-editor\" data-id=\"8378618\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>CPI 0610-04, MANIFEST-2 &#8211; \u03bf\u03bb\u03bf\u03ba\u03bb\u03b7\u03c1\u03ce\u03b8\u03b7\u03ba\u03b5 \u03b7 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd,\u00a0 \u00a0Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI-0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naive MF Patients,\u00a0 &#8211; \u03a5\u03c0\u03b5\u03cd\u03b8\u03c5\u03bd\u03b7 \u03ba\u03cd\u03c1\u03b9\u03b1 \u03b5\u03c1\u03b5\u03c5\u03bd\u03ae\u03c4\u03c1\u03b9\u03b1 \u0395\u03bb. \u03a7\u03b1\u03c4\u03b6\u03b7\u03bc\u03b9\u03c7\u03b1\u03ae\u03bb\u00a0<\/li><li>ENESTPath<strong>, <\/strong>A clinical research study evaluating the possibility to suspend the drug nilotinib (Tasigna) in chronic myeloid leukemia (CML) patients who have been for two different durations on Tasigna with a predefined level of molecular response., Prof E. Briasoulis, E. Kapsali<\/li><li>Management of Chronic Myeloid Leukemia (CML) with dasatinib in a Real-world setting, Sponsor: Hellenic Society of Haematology, PI E. Kapsali<\/li><li>An observational study of the impact on the quality of life, effectiveness and safety of ruxolitinib in patients with primary or secondary post-polycythemia vera or post- essential thrombocythemia myelofibrosis: The &#8220;ESCAPE&#8221; study, PI E. Briasoulis, E. Kapsali<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-48c0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"48c0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;ed968d4&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b16e177\" data-id=\"b16e177\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6cb5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6cb5\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;0e7bf6d&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-30ec\" data-id=\"30ec\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-29f9 elementor-widget elementor-widget-heading\" data-id=\"29f9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">\u0393\u03c1\u03b1\u03c6\u03b5\u03af\u03bf \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ce\u03bd \u03b4\u03bf\u03ba\u03b9\u03bc\u03ce\u03bd<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-179f elementor-widget elementor-widget-heading\" data-id=\"179f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\"><a href=\"tel:00302651099859\">\u03a4: +302651099650<\/a><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\u0395\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u039c\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u0388\u03c1\u03b3\u03bf \u03b5\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 0 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ad\u03c2 \u03b3\u03b9\u03b1 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd 0 \u0397 \u0391\u03b9\u03bc\u03b1\u03c4\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u039a\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03ad\u03c7\u03b5\u03b9 \u03c0\u03c1\u03bf\u03c3\u03b5\u03bb\u03ba\u03cd\u03c3\u03b5\u03b9 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03c6\u03ac\u03c3\u03b7\u03c2 I\u0399-IV \u03b5\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c0\u03c1\u03cc\u03c3\u03b2\u03b1\u03c3\u03b7 \u03c4\u03c9\u03bd \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03c3\u03b5 \u03ba\u03b1\u03b9\u03bd\u03bf\u03c4\u03cc\u03bc\u03b5\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b5\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03b1\u03c1\u03ad\u03c7\u03bf\u03bd\u03c4\u03b1\u03c2 \u03b1\u03be\u03b9\u03cc\u03c0\u03b9\u03c3\u03c4\u03b1 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1. \u03a0\u03b1\u03c1\u03b1\u03ba\u03ac\u03c4\u03c9 \u03bc\u03c0\u03bf\u03c1\u03b5\u03af\u03c4\u03b5 \u03bd\u03b1 \u03b4\u03b5\u03af\u03c4\u03b5 \u03c0\u03bf\u03b9\u03b5\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b5\u03bd\u03b5\u03c1\u03b3\u03b5\u03af\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bf\u03b9\u03ad\u03c2 \u03b1\u03bd\u03bf\u03b9\u03ba\u03c4\u03ad\u03c2 \u03c0\u03c1\u03bf\u03c2 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03a0\u03bf\u03bb\u03bb\u03b1\u03c0\u03bb\u03cc \u039c\u03c5\u03ad\u03bb\u03c9\u03bc\u03b1 \u03a0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ad\u03c2 TRIlogy-5 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":63,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"page-templates\/fullwidth-content.php","meta":{"footnotes":""},"class_list":["post-1283","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/pages\/1283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/comments?post=1283"}],"version-history":[{"count":224,"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/pages\/1283\/revisions"}],"predecessor-version":[{"id":5342,"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/pages\/1283\/revisions\/5342"}],"up":[{"embeddable":true,"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/pages\/63"}],"wp:attachment":[{"href":"https:\/\/haematology.med.uoi.gr\/en\/wp-json\/wp\/v2\/media?parent=1283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}